News | November 14, 2014

Prestige Medical Imaging Partners With VuComp Inc. For New Technologies to Detect Breast Cancer

M-Vu Breast Density is designed to advance the science of breast density measurement by identifying dense tissue in the breast that could be masking cancer.

Nov. 14, 2014 – Prestige Medical Imaging (PMI) will partner with VuCOMP Inc., a developer of advanced computer vision systems for the detection of breast cancer. VuCOMP has developed and commercialized two breast-imaging products, M-Vu CAD and M-Vu Breast Density. M-Vu CAD analyzes mammograms to mark areas consistent with breast cancer using sophisticated mathematical algorithms.

M-Vu Breast Density is designed to advance the science of breast density measurement by identifying dense tissue in the breast that could be masking cancer. In addition, VuCOMP has a works-in-progress CAD solution for 3-D breast tomosynthesis in development.

CEO of Prestige Medical Imaging Bill Haussmann, Chief Executive Officer commented, “Our customers are requiring more advanced technology in performing diagnostic exams particularly with reading dense breast tissue mammography exams. The addition of VuCOMP’s innovative technology to Prestige Medical Imaging’s portfolio addresses these needs by offering an automated, consistent and efficient assessment tool. This offering expands our portfolio and extends our market reach into Women’s Healthcare.”

For more information: www.prestigemedicalimaging.com, www.vucomp.com

Related Content

Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr

Productivity and Patient Benefits May Come From Wire-free Lumpectomy

Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr

Vendor Strategies Provide Glimpse of Women’s Health Future

Signs of what the future may look like in women’s health dotted the exhibit floor of the...

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr

Development of Artificial Intelligence in Women’s Health Emphasizes Value

Commercial efforts to develop...

News | Artificial Intelligence | April 18, 2019

Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer

University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...

Videos | Breast Imaging | April 18, 2019

VIDEO: Age, Interval and Other Considerations for Breast Screening

In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr

How Risk Stratification Might Affect Women’s Health

When planning a screening program to detect the early signs of breast cancer, age is a major consideration.